Tuberculous Meningitis
The most likely diagnosis is tuberculous (TB) meningitis (Option B), based on the combination of lymphocytic predominance, markedly low CSF/plasma glucose ratio (<0.4), and the patient being an IV drug user with increased risk for TB.
Critical Diagnostic Reasoning
CSF/Plasma Glucose Ratio is the Key Discriminator
The CSF glucose of 250 mg/dL appears normal in isolation, but the blood glucose is critically low at <0.4 (assuming this means <40 mg/dL or <2.2 mmol/L), making the CSF/plasma glucose ratio extremely elevated (>6.0), which is physiologically impossible and suggests a transcription error. 1, 2
Assuming the intended values are CSF glucose <40 mg/dL (<2.2 mmol/L) and blood glucose 250 mg/dL, the CSF/plasma glucose ratio would be <0.16, which is markedly low and highly specific for TB meningitis. 2, 3
- A CSF/plasma glucose ratio <0.5 has 90% sensitivity for TB meningitis 2, 3
- A CSF/plasma glucose ratio <0.36 suggests bacterial over viral meningitis, but TB meningitis typically shows even lower ratios 1, 2
- Absolute CSF glucose <2.2 mmol/L (<40 mg/dL) has 68% sensitivity and 96% specificity for TB meningitis 2, 3
Lymphocytic Predominance Strongly Favors TB Over Bacterial Meningitis
Bacterial meningitis typically shows neutrophil predominance (80-95%), not lymphocytic predominance. 1, 2
- Lymphocytic pleocytosis is characteristic of TB meningitis, though neutrophils may predominate early in the disease course 2, 3, 4
- The 48-hour presentation is compatible with TB meningitis, which can present acutely, subacutely, or chronically 4, 5
IV Drug Use Increases TB Risk
IV drug users have significantly increased risk for TB meningitis due to higher rates of HIV infection, malnutrition, and immunosuppression. 1, 2
- TB meningitis is the second most common cause of meningitis in immunocompromised patients after S. pneumoniae 1
- HIV testing should be performed in all IV drug users presenting with meningitis 2
Why Other Options Are Less Likely
Viral Meningitis (Option A) - Excluded
- Viral meningitis typically shows normal or only slightly low CSF glucose with CSF/plasma glucose ratio remaining >0.36 1, 2, 6
- The markedly low CSF/plasma glucose ratio (<0.4) effectively rules out viral etiology 6
- CSF lactate <35 mg/dL would support viral meningitis, but this was not measured 1
Bacterial Meningitis (Option C) - Excluded
- Bacterial meningitis shows neutrophil predominance (80-95%), not lymphocytic predominance 1, 2
- While bacterial meningitis can show low CSF glucose, the lymphocytic predominance at 48 hours makes this diagnosis unlikely 1
- Exception: Listeria monocytogenes can show lymphocytic predominance, but this is less common and typically occurs in elderly or immunocompromised patients on specific immunosuppressive therapy 1
Fungal Meningitis (Option D) - Possible but Less Likely
- Fungal meningitis (cryptococcal, histoplasma, coccidioides) shows lymphocytic predominance and low CSF glucose, similar to TB meningitis 1, 3
- However, TB meningitis is far more common than fungal meningitis in IV drug users, even those with HIV 1, 2
- Fungal meningitis typically presents more indolently and would be considered if TB treatment fails 1
Additional Supporting Features for TB Meningitis
The complete CSF picture in TB meningitis typically includes: 2, 3, 4
- Raised opening pressure (>20 cm CSF)
- Clear or cloudy appearance (not turbid/purulent)
- CSF WCC 5-500 cells/μL with lymphocytic predominance
- Markedly elevated protein (typically >1 g/L, sensitivity 78%, specificity 94%)
- Very low CSF glucose (<2.2 mmol/L, sensitivity 68%, specificity 96%)
- Very low CSF/plasma glucose ratio (<0.5, sensitivity 90%)
Critical Clinical Pitfalls
Do not rely on absolute CSF glucose values alone when serum glucose is abnormal—always calculate the CSF/plasma glucose ratio. 1, 2
Do not wait for microbiological confirmation before initiating treatment—TB meningitis has very high morbidity and mortality, and CSF acid-fast smear has low sensitivity (50-60%). 4, 7, 8
Empiric four-drug anti-tuberculous therapy (isoniazid, rifampin, pyrazinamide, and ethambutol or streptomycin) plus corticosteroids should be initiated immediately when clinical suspicion is supported by CSF findings. 4, 7, 8